Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis

Liver

Volumn 16, Issue 4, 1996, Pages 274-282

  Protzer, U ^a   Dienes, H P ^a   Bianchi, L ^b   Lohse, A W ^a   Helmreich Becker, I ^a   Gerken, G ^a   Meyer Zum Buschenfelde K H ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Autoimmune hepatitis; Giant cell formation; Immunosuppressive treatment; PIGCH; PSC; Ursodeoxycholic acid

Indexed keywords

AMINOTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; URSODEOXYCHOLIC ACID;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLESTASIS; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GIANT CELL; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL; MALE; PATHOGENESIS; PRIMARY SCLEROSING CHOLANGITIS; SEPSIS;

EID: 0029740075     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00743.x     Document Type: Article

References (33)

1. THALER H. Post-infantile giant cell hepatitis. Liver 1982: 2: 393-403.
2. LAU J Y N, KOUKOULIS G, MIEL-VERGANI G, PORTMANN B C, WILLIAMS R. Syncytial giant-cell hepatitis - a specific disease entity? J Hepatol 1992: 15: 216-219.
3. WITZLEBEN C L, MARSHALL G S, WERNER W, PICCOLI D A, BARBOUR S D. HIV as a cause of giant cell hepatitis. Hum Pathol 1988: 19: 603-605.
4. GAUR S, ROSENTHAL S, DADHANIA J, et al. Cholestatic giant cell hepatitis associated with ultrastructural evidence of intrahepatic retroviral infection in a human immunodeficiency virus-seropositive infant. J Pediatr Gastroenterol Nutr 1993: 16: 199-202.
5. RICHEY J, ROGERS S, VAN THIEL D H, LESTER R. Giant multinucleated hepatocytes in an adult with chronic active hepatitis. Gastroenterology 1977: 73: 570-574.
6. PESSAYRE D, DEGOS F, FELDMANN G, DEGOTT C, BERNUAU J, BENHAMOU J-P. Chronic active hepatitis and giant multinucleated hepatocytes in adults treated with clometacin. Digestion 1981: 22: 66-72.
7. LEFKOWITCH J H, APFELBAUM T F, WEINBERG L, FORESTER G. Acute liver biopsy lesions in early autoimmune ("lupoid") chronic active hepatitis. Liver 1984: 4: 379-386.
8. THIJS J C, BOSMA A, HENZEN-LOGMANS S C, MEUWISSEN S G M. Postinfantile giant cell hepatitis in a patient with multiple autoimmune features. Am J Gastroenterol 1985: 80: 294-297.
9. PAPPO O, YUNIS E, JORDAN J A, et al. Recurrent and de novo giant cell hepatitis after orthotopic liver transplantation. Am J Surg Pathol 1994: 18: 804-813.
10. MAYET W J, HESS G, GERKEN G, et al. Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 1989: 10: 24-28.
11. GOERGEN B, JAKOBS S, SYMMONS P, HORNES E, MEYER ZUM BÜSCHENFELDE K H, GERKEN G. Quantitation of HCV-replication using one-step competitive RT-PCR and a solid phase, colorimetric detection method. J Hepatol 1994: 21: 678-682.
12. TREICHEL U, GERKEN G, ROSSOL S, ROTTHAUWE H W, MEYER ZUM BÜSCHENFELDE K H, PORALLA T. Autoantibodies against the human asialogycoprotein receptor effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol 1993: 19: 5563.
13. JOHNSON P J, MCFARLANE I G. Convenors, on Behalf of the Panel. Meeting Report International Autoimmune Hepatitis Group. Hepatology 1993: 18: 998-1005.
14. CZAJA A J, CARPENTER H A, SANTRACH P J, MOORE S B. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 1993: 105: 1502-1507.
15. MINUK G Y, SUTHERLAND L R, PAPPAS S C, KELLY J K, MARTIN S E. Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can J Gastroenterol 1988: 2: 22-27.
16. RABINOVITZ M, DEMETRIS A J, BOU-ABBOUD C F, VAN THIEL D H. Simultaneous occurence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992: 37: 1606-1611.
17. LEGGETT B A, HALLAM A, POWELL E E, POWELL L W. Autoimmune chronic hepatitis evolving to primary sclerosing cholangitis: evidence for a common pathogenesis (abstract). Hepatology 1992: 16: 191A.
18. LAWRENCE S P, SHERMAN K E, LAWSON J M, GOODMAN Z D. A 39 year old man with chronic hepatitis. Sem Liv Dis 1994: 14: 97-105.
19. 1-antioypsin deficiency. Hepatology 1988: 8: 307-310.
20. BRICHARD B, SOKAL E, GOSSEEYE S, BURS J P, GADISSEUX J F, CORNU G. Coombs-positive giant cell hepatitis of infancy: effect of steroid and azathioprine therapy. Eur J Pediatr 1991: 150: 314-317.
21. CLAYTON P T, LEONARD J V, LAWSON A M, et al. Familial giant cell hepatitis associated with synthesis of 3β, 7α-dihydroxy- and 3β7α,12α-trihydroxy-5-cholenoic acids. J Clin Invest 1987: 79: 1031-1038.
22. HASHIDA Y, YUNIS E J. Syndromatic paucity of interlobular bile ducts: hepatic histophathology of the early and end-stage liver. Pediatr Pathol 1988: 8: 1-15.
23. OMATA M, JOHNSON C S, TONG M, TATIER D. Pathological spectrum of liver diseases in sickle cell disease. Dig Dis Sci 1986: 31: 247-256.
24. DEVANEY K, GOODMAN Z D, ISHAK K G. Postinfantile giant-cell transformation in hepatitis. Hepatology 1992: 16: 327-333.
25. PHILLIPS M J, BLENDIS L M, POUCELL S, et al. Syncytial giant-cell hepatitis, sporadic hepatitis with distinctive pathological features, a severe clinical course and paramyxoviral features. N Engl J Med 1991: 324: 455-460.
26. Case records of the Massachusettes General Hospital (case 34). N Engl J Med 1988: 319: 495-509.
27. Editorial. Hepatitis G? Lancet 1991: 337: 1070-1071.
28. DIENES H-P, PROTZER U, BIANCHI L, SCHIRMACHER P, KLINGE O, MEYER ZUM BÜSCHENFELDE K-H. Pathogenesis and clinical relevance of postinfantile giant cell hepatitis (PIGCH) (abstract). Hepatology 1993: 18: S 70A.
29. BEN-ARI Z, DHILLON A P, SHERLOCK S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993: 18: 10-15.
30. MICHIELETTI P, WANLESS I R, KATZ A, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndome of autoimmune cholangitis. Gut 1994: 35: 260-265.
31. RABINOVITZ M, DEMETRIS A J. Postinfantile giant cell hepatitis associated with anti-M2 mitochondrial antibodies. Gastroenterology 1994: 197: 1162-1164.
32. STIEHL A, WALKER S, STIEHL L, RUDOLPH G, HOFMANN W J, THEILMANN L. Effect of ursodeoxycholic acid on liver and bite duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol 1994: 20: 57-64.
33. BEUERS U, SPENGLER U, KRUIS W, et al. Ursodeoxycholic acid for treatment of primary sclerosing colangitis: a placebo-controlled trial. Hepatology 1992: 16: 707-714.